Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant group (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant group (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
-
1521
Image 4_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif
Published 2025“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
-
1522
Image 2_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif
Published 2025“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
-
1523
Table 3_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.xlsx
Published 2025“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
-
1524
Image 1_PABPN1 as a pan-cancer biomarker: prognostic significance and association with tumor immune microenvironment.tif
Published 2025“…After down expression of PABPN1, mRNA expression levels of MRPS15 and GPx (Glutathione peroxidase) decreased significantly in T24, 5637 HLF and MCF-7 cells.…”
-
1525
-
1526
-
1527
-
1528
-
1529
-
1530
-
1531
IRs -EGFP-N1 (red) in transfected HEK 293T cells assessed by confocal microscopy.
Published 2025Subjects: -
1532
-
1533
-
1534
Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription...
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
1535
Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n...
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
1536
Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
1537
Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
1538
Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8...
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
1539
Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.
Published 2024Subjects: “…fluoroquinolone shares decreased…”
-
1540
UTI diagnoses by sex and physician specialty (2013–2019).
Published 2024Subjects: “…fluoroquinolone shares decreased…”